<DOC>
	<DOCNO>NCT02572349</DOCNO>
	<brief_summary>The objective study assess safety tolerability range single dose IW-1701 administered oral capsule healthy subject , determine pharmacokinetic profile pharmacodynamics effect range single dos IW-1701 administer oral capsule healthy subject .</brief_summary>
	<brief_title>Trial IW-1701 ( A Stimulator Soluble Guanylate Cyclase ( sGC ) ) Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion : Between 18 60 year old Screening Visit ; Women childbearing potential must negative pregnancy test must agree use doublebarrier contraception ; BMI &gt; 18.5 &lt; 32.0 kg/m2 Screening Visit ; In overall good health clinically significant laboratory , ECG , physical exam finding ; Other inclusion criterion per protocol . Exclusion : History clinicallysignificant medical condition ; Other exclusion criterion per protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>